RaymondsIndex

A year ago, three Korean financial regulators — the Financial Services Commission, the Financial Supervisory Service, and the Korea Exchange — folded their separate manipulation desks into one joint unit. This week they published a first-year scorecard: more than ten unfair-trading cases handed to prosecutors, and a headcount that has grown from 36 to 90, with a target of 100. The flagship "life-ruining" case involved a group of wealthy professionals — hospital and academy owners among them — running a long-running scheme estimated in the hundreds of billions of won. Other cases included a brokerage executive who traded on non-public takeover information and a journalist who front-ran his own coverage. Read those cases side by side and a single shape emerges. In each one, someone knew first, and the person on the other side of the trade did not. That is the definition of information asymmetry, and it is the quiet engine behind most retail losses. The manipulation is visible ...

There is a particular kind of failure that doesn't look like failure at all. The loan keeps performing. The covenants hold. The quarterly statements arrive on time. And yet the company underneath is quietly running out of the one thing that keeps a business alive — the capacity to reinvest in itself. This week, that pattern showed up most clearly in private credit. When a borrower can no longer pay interest out of operating cash flow, a growing share of loans don't default; they convert to payment-in-kind (PIK), where the unpaid interest is simply capitalized onto the principal. The debt keeps "performing" on paper. But as one industry analysis put it, the operating pressure is deferred, not resolved. Fitch's U.S. private credit default rate has risen from 4.6% at the end of 2024 to 5.8% by January 2026. More telling is the sentiment inside the industry itself: in Ocorian's May 2026 survey of 300 private-capital executives, 96% expect PIK usage to increase ov...

Every capital raise comes wrapped in a story of growth. But the most honest line in any prospectus is rarely the vision — it's the use-of-proceeds table. That table tells you the direction of the money, and direction is destiny. This week offered a clean illustration. A KOSDAQ-listed small-cap finalized the price (July 6) on a ₩22.9 billion rights offering with a public-offering backstop, opening shareholder subscription on July 9–10. The stated allocation: roughly ₩17 billion — about 74% — for debt repayment, and the remaining ₩5.9 billion for working capital. Shortly before, the company had executed a share consolidation, folding its par value from ₩100 to ₩500. New equity from minority shareholders, the bulk of it flowing not into the business but back out to lenders. There is nothing illegal here, and debt repayment can be prudent. But for the investor writing the check, the economics are worth stating plainly: your fresh capital is not buying new capacity, new products, or n...

Every balance sheet with a large cash balance tells two stories at once. In one, the cash is dry powder — reserves waiting for the right investment, the right acquisition, the right moment to compound. In the other, the cash is a resting place — capital that has stopped moving because moving it would expose a decision no one wants to make. The trouble for an outside investor is that both stories look identical on the page. The number is the same. Only the intent differs, and intent is exactly what a financial statement cannot show you. The concept: Capital Efficiency. RaymondsIndex operationalizes this through the Capital Efficiency Index (CEI) — one of four leading signals, weighted at 45% alongside the Cash Governance Index. CEI measures return on invested capital, asset turnover, and the gap between what a company earns and what it puts back to work. A low and drifting CEI is the fingerprint of capital that has gone quiet: assets that no longer turn, returns that no longer justify...

1. The news. This Monday, July 6, marks the endgame for UTILEX, a KOSDAQ-listed immunotherapy developer. Its shares have not traded since February 9, when auditors issued a disclaimer of opinion on the 2025 financial statements, citing going-concern uncertainty and a scope limitation. The audit report showed current liabilities exceeding current assets by KRW 12.3 billion. On July 2, the Korea Exchange confirmed delisting for July 15, with liquidation trading scheduled to begin July 6 — and the company answered with an injunction filing that froze trading entirely. On the same day, another KOSDAQ name, Incredible Buzz, entered its own trading suspension. And in Sydney, WiseTech Global — one of Australia's flagship tech companies — shed roughly 12% in a single session in late June after reports that federal police are investigating its founder-chairman, who remains the largest shareholder while a separate regulatory review examines his share trades during a 2025 blackout period. 2....

Two regulatory events this week frame today's deep dive better than any hypothetical could. On July 1, Korea's strengthened delisting rules took effect. Market-cap floors rose to 30 billion won for KOSPI and 20 billion won for KOSDAQ (rising again in January 2027). A new penny-stock rule puts companies trading below 1,000 won for 30 consecutive sessions on the watchlist. And full capital impairment now triggers delisting review at the half-year mark — regulators no longer wait for the annual report. Meanwhile in Washington, the House took up an NDAA amendment that would bar major defense contractors — companies drawing more than half their revenue from Pentagon contracts — from buying back their own stock. The Senate Armed Services Committee adopted an even broader version covering dividends and other capital distributions. The U.S. Chamber of Commerce, the Aerospace Industries Association, and the Business Roundtable urged the House Rules Committee to reject it, calling buybac...